By Editor • August 28, 2026 • 1 min read
Juul Labs has received FDA approval for a new e-cigarette with age-verification technology to combat underage usage.
Read moreBy Editor • August 28, 2026 • 1 min read
Cytokinetics reveals positive data for aficamten, targeting nHCM, and plans FDA submission by year-end for potential approval.
Read moreBy Editor • August 28, 2026 • 1 min read
The FDA has approved updated Covid-19 vaccines targeting the XFG variant, allowing manufacturers to start shipping doses amid insurance coverage uncertainties.
Read moreBy Editor • August 27, 2026 • 1 min read
The FDA has approved Roivant's Lisraya, a new daily pill for treating dermatomyositis, a rare autoimmune disease affecting up to 70,000 people in the U.S.
Read moreBy Editor • August 27, 2026 • 1 min read
The FDA has approved a new pancreatic cancer drug by Revolution Medicines, showing a median survival increase in patients.
Read moreBy Editor • August 26, 2026 • 1 min read
The FDA has approved Rasonque, a drug that doubles survival rates for advanced pancreatic cancer patients, offering new hope and treatment options.
Read moreBy Editor • August 26, 2026 • 1 min read
Over 54,000 pounds of Lundberg jasmine rice have been recalled due to possible contamination; consumers should discard affected packages.
Read moreBy Editor • August 26, 2026 • 1 min read
The FDA has approved daraxonrasib, a pioneering pill for pancreatic cancer that blocks a protein responsible for tumor growth in over 90% of cases.
Read moreBy Editor • August 26, 2026 • 1 min read
The FDA has approved Rasonque, a new treatment for advanced pancreatic cancer, showing promising survival rates in clinical trials.
Read moreBy Editor • August 24, 2026 • 1 min read
The FDA has paused Regenxbio's gene therapy trials for Hunter syndrome due to safety concerns after five patients showed spine masses.
Read more
